The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[(1S,2S)-2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-1,3-dihydro-indol-2-one ID: ALA427116
PubChem CID: 9929020
Max Phase: Preclinical
Molecular Formula: C23H28N2O2
Molecular Weight: 364.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]([C@@H](O)c1ccc2c(c1)CC(=O)N2)N1CCC(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C23H28N2O2/c1-16(23(27)19-7-8-21-20(14-19)15-22(26)24-21)25-11-9-18(10-12-25)13-17-5-3-2-4-6-17/h2-8,14,16,18,23,27H,9-13,15H2,1H3,(H,24,26)/t16-,23+/m0/s1
Standard InChI Key: FCXXSNGUDWIOQU-QMHKHESXSA-N
Molfile:
RDKit 2D
27 30 0 0 1 0 0 0 0 0999 V2000
-0.2708 -4.0375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9125 -2.9917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6250 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3125 -3.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3042 -3.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3542 -3.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -3.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8792 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2625 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2250 -3.5375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4292 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9167 -2.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3417 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8292 -4.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8792 -2.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4792 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9500 -3.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -2.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9542 -2.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9917 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9917 -3.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5167 -2.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -2.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5125 -3.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -3.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 1 1 0
4 5 2 0
5 1 1 0
6 14 1 0
7 8 1 0
8 6 1 0
9 4 1 0
10 3 1 0
11 3 2 0
12 2 1 0
13 2 1 0
14 15 2 0
15 5 1 0
8 16 1 6
17 20 1 0
18 12 1 0
19 13 1 0
20 19 1 0
21 17 1 0
7 22 1 1
23 21 2 0
24 21 1 0
25 24 2 0
26 23 1 0
27 25 1 0
4 10 1 0
9 6 2 0
18 20 1 0
26 27 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.49Molecular Weight (Monoisotopic): 364.2151AlogP: 3.56#Rotatable Bonds: 5Polar Surface Area: 52.57Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.18CX Basic pKa: 9.11CX LogP: 3.52CX LogD: 1.80Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.85Np Likeness Score: -0.27
References 1. Chenard B, Butler T, Shalaby I, Prochniak M, Koe B, Fox C. (1993) Oxindole N-Methyl-D-Aspartate (NMDA) antagonists, 3 (1): [10.1016/S0960-894X(00)80098-0 ]